Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - azitromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

csl behring gmbh, nemecko - c1-inhibítor, derivát plazmy - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

octapharma (ip) sprl, belgicko - Ľudský fibrinogén - 75 - substitutio sanguinis (a krvnÉ derivÁty)

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidín - leukémia, myeloidná, akútna - antineoplastické činidlá - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. pozri časti 4. 4 a 5.